Omeros (NASDAQ: OMER) reports $171.5M cash, short-term investments

Rhea-AI Filing Summary

Omeros Corporation disclosed preliminary year-end liquidity figures following an investor call. The company reported that at December 31, 2025, it had approximately $171.5 million in cash and short-term investments available for operations. This amount is described as preliminary and unaudited and may change after the company completes its customary financial closing procedures and adjustments.

The disclosure is provided under a current report and is specifically designated as “furnished” rather than “filed,” meaning it is not subject to certain liability provisions and will not automatically be incorporated into other securities filings.

false 0001285819 0001285819 2026-01-07 2026-01-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 7, 2026

OMEROS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Washington	001-34475	91-1663741
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

201 Elliott Avenue West Seattle, WA		98119
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (206) 676-5000

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered Pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value per share	OMER	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).         

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

As previously announced, on January 7, 2026, Omeros Corporation (the “Company” or “we”) held a conference call and webcast for investors, the prepared remarks for which included disclosure of certain preliminary, unaudited financial information for the fiscal year ended December 31, 2025. Accordingly, and consistent with the requirements of Item 2.02 of Form 8-K, this filing is being made to report that at December 31, 2025, we had approximately $171.5 million of cash and short-term investments available for operations. This figure is preliminary and unaudited. It is subject to completion of the Company’s customary financial closing procedures and adjustments.

The information in this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein shall not be incorporated by reference into any filing with the United States Securities and Exchange Commission made by Omeros Corporation, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	OMEROS CORPORATION
Date: January 7, 2026	By:	/s/ Gregory A. Demopulos
		Gregory A. Demopulos, M.D.
		President, Chief Executive Officer and
		Chairman of the Board of Directors

FAQ

What preliminary cash balance did Omeros (OMER) report for year-end 2025?

Omeros reported that at December 31, 2025, it had approximately $171.5 million in cash and short-term investments available for operations. This figure is preliminary and unaudited.

Is the $171.5 million cash figure for Omeros final and audited?

No. Omeros states the approximately $171.5 million cash and short-term investments balance is preliminary and unaudited and is subject to completion of its customary financial closing procedures and adjustments.

For what date does Omeros (OMER) report its $171.5 million cash and investments?

The approximately $171.5 million of cash and short-term investments is reported as of December 31, 2025, the end of Omeros’ fiscal year.

Why did Omeros file this Form 8-K about its cash and investments?

Omeros filed this report because its prepared remarks on a January 7, 2026 investor conference call included preliminary financial information, including the year-end cash and short-term investments balance.

Does this Omeros 8-K incorporate the information into other SEC filings?

No. Omeros specifies that the information is not incorporated by reference into other SEC filings, regardless of any general incorporation language in those filings.

Is the Omeros 8-K cash disclosure considered "filed" with the SEC?

Omeros states that the information is being furnished on Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.